Abstract
This review paper sets out to evaluate the evidence for different modalities as first-line treatments for primary open-angle glaucoma. In current practice, initial treatment is commonly with medical therapy, whereas laser, or incisional surgery, is performed if medical therapy does not satisfactorily reduce initial intra-ocular pressure and/or prevent visual field progression. However, medical therapy is not without adverse effects, and poor compliance with treatment means that in some cases another primary therapy might be preferable. Glaucoma is a common, chronic disease requiring life-long care in order to prevent progressive optic nerve head atrophy and blindness. Demographic changes in the developed world are resulting in a growing treated population: issues concerning acceptability, efficiency and cost-effectiveness of initial glaucoma treatment will become increasingly important.
Original language | English |
---|---|
Pages (from-to) | 587-594 |
Number of pages | 8 |
Journal | Expert Review of Ophthalmology |
Volume | 8 |
Issue number | 6 |
DOIs | |
State | Published - 2013 |
Keywords
- ALT
- Alpha-agonist
- Beta-blocker
- Carbonic anhydrase inhibitor
- Medical treatment
- Open-angle glaucoma
- Prostaglandin
- SLT
- Trabeculectomy
- Trabeculoplasty